Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Vivia Biotech logo — Compound Profiling and Translational CRO to enable Cancer Dr...

Vivia Biotech

Compound Profiling and Translational CRO to enable Cancer Drug and Biomarker Discovery & Development

Founded 2007 Spain Spain 29 employees Series B Biotechnology, Life Sciences +1

General Information

Company Name Vivia Biotech
Founded Year 2007
Location Spain Spain
Employees 29
Industries Biotechnology, Life Sciences, Pharmaceutical
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Vivia Biotech. To contact Vivia Biotech, visit viviabiotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Vivia Biotech compare?

A PDF of Vivia Biotech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Vivia Biotech soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Vivia Biotech

ViviaBiotech pioneers scale systems biology screening directly in patient samples, systematically searching for new indications of known drugs (reprofiling) in Hematological Cancers (HC) and Autoimmune Disorders, based on the first platform technology (PharmaFlow) capable of screening thousands of drugs (or combinations) directly on a patient's sample while it is still fresh (24/48 hours). Analyzing the effect of drugs in the live biological system where the disease operates enables Vivia to identify novel mechanism of action of existing drugs never before observed. With this innovative approach, Vivia has identified in less than a year several non-cytotoxic known drugs with proven safety profiles in humans, that kill selectively malignant cells ex vivo with better efficacy as the approved cytotoxics used in the treatment of several Hematological Cancers. Among those it has selected a lead compound that expects to enter clinical trials in Chronic Lymphocytic Leukemia .

No funding data available for Vivia Biotech yet.

FAQ About Vivia Biotech

Compound Profiling and Translational CRO to enable Cancer Drug and Biomarker Discovery & Development
Vivia Biotech was founded in 2007.
Vivia Biotech is headquartered in Spain.
Vivia Biotech operates in Biotechnology, Life Sciences and Pharmaceutical.
Vivia Biotech has approximately 29 employees.

We're actively collecting intelligence on Vivia Biotech.

Source: BounceWatch company record for Vivia Biotech, https://bouncewatch.com/company/vivia-biotech, updated 14 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes